Get the Stockscreener App
0.766
4.55%
-0.0365
After Hours:
.78
0.014
+1.83%
Pavmed Inc Stock (PAVM) Latest News
Lucid Diagnostics Restores Nasdaq Listing Compliance - Nasdaq
Lucid Diagnostics meets Nasdaq minimum bid price rule By Investing.com - Investing.com South Africa
Lucid Diagnostics meets Nasdaq minimum bid price rule - Investing.com
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement – Company Announcement - Financial Times
PAVmed, Veris Health complete private placement financing - Medical Buyer
Can This New Cancer Monitoring Device Transform Patient Care? PAVmed Secures Crucial Funding - StockTitan
PAVmed, Veris Health finalize private placement financing - Philanthropy News Digest
Lucid Diagnostics secures concierge medicine contract By Investing.com - Investing.com Nigeria
LUCDLucid Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
Can Lucid's New Concierge Medicine Deal Transform Its Revenue Model? - StockTitan
PAVmed regains Nasdaq compliance - MSN
PAVmed Regains Compliance with Nasdaq Listing Standards**WASHINGTON, DC—In a recent 8-K filing with the Securities and Exchange Commission, PAVmed Inc. (NASDAQ: PAVM) announced that it has successfully regained compliance with the Nasda - Defense World
PAVmed regains compliance with Nasdaq Capital Market’s CLS - Medical Buyer
PAVMPavmed Latest Stock News & Market Updates - StockTitan
PAVmed regains Nasdaq compliance with stockholders' equity By Investing.com - Investing.com Canada
PAVmed Regains Compliance With Nasdaq Listing Standards -February 18, 2025 at 10:07 am EST - Marketscreener.com
PAVmed regains Nasdaq compliance with stockholders’ equity By Investing.com - Investing.com Nigeria
PAVmed regains Nasdaq compliance with stockholders' equity - Investing.com
PAVmed regains Nasdaq compliance with equity boost By Investing.com - Investing.com South Africa
Innovative Tech Company Surges Forward: PAVmed Triumphs in Nasdaq Compliance - Smartphone Magazine
PAVmed regains Nasdaq compliance with equity boost - Investing.com India
Navigating the High Seas of Market Compliance: PAVmed’s Resilient Return - Mi Valle
PAVmed Triumphs on Nasdaq: A Medical Tech Comeback Story - Jomfruland.net
Critical Victory: PAVmed's Strategic Moves Save Nasdaq StatusFull Details Inside - StockTitan
SI-BONE (NASDAQ:SIBN) vs. Lucid Diagnostics (NASDAQ:LUCD) Head to Head Survey - Defense World
PAVmed stock touches 52-week low at $0.57 amid market challenges - MSN
Lucid Diagnostics (NASDAQ:LUCD) vs. Insulet (NASDAQ:PODD) Head-To-Head Review - Defense World
Lucid Diagnostics Inc (LUCD) Shares Rise Despite Market Challenges - The News Heater
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Marketscreener.com
PAVmed to Host Earnings Call - ACCESS Newswire
Lucid Diagnostics Provides Business Update and Second Quarter 20 - GuruFocus.com
PAVMed faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
PAVMed faces Nasdaq delisting over share price rule - Investing.com
PAVmed shareholders approve stock issuance and charter amendment - Investing.com India
PAVmed shareholders approve stock issuance and charter amendment By Investing.com - Investing.com Australia
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - PR Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit - Kilgore News Herald
Lucid Inks New Partnership With VITALExam: Stock to Gain? - MSN
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophag - GuruFocus.com
Lucid Gains Extension of Compliance by NASDAQ - Baystreet.ca
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - Marketscreener.com
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Eastern Progress Online
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters - GuruFocus.com
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test - The Eastern Progress Online
PAVmed stock plunges to 52-week low, touches $0.6 By Investing.com - Investing.com Canada
PAVmed stock plunges to 52-week low, touches $0.6 - Investing.com
1.29%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):